Volume 101 Number 6
Published online 8 September 2009 (875 - 1032)
---------------------------------------------------------------------
British Journal of Cancer publishes high quality original papers and
reviews that make a significant contribution to increasing
understanding of the causes of cancer and to improving the treatment
and survival of patients.
Visit the journal online at http://links.ealert.nature.com/ctt?kn=31&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0 to view the
latest research and access selected articles FREE of charge.
---------------------------------------------------------------------
British Journal of Cancer has an impact factor of 4.846*
2008 Journal Citation Reports (Thomson Reuters, 2009)
----------------------
MINIREVIEW
----------------------
Tamoxifen: the drug that came in from the cold
L Hughes-Davies, C Caldas and G C Wishart
Abstract: http://links.ealert.nature.com/ctt?kn=5&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=70&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
----------------------
EDITORIAL
----------------------
Cost-effectiveness of computed tomography lung cancer screening
Jerome M Reich
http://links.ealert.nature.com/ctt?kn=68&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Cost of a 5-year lung cancer survivor
S W Duffy
http://links.ealert.nature.com/ctt?kn=74&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
----------------------
CLINICAL STUDIES
----------------------
Cost of a 5-year lung cancer survivor: symptomatic tumour
identification vs proactive computed tomography screening
A W Castleberry, D Smith, C Anderson, A J Rotter and
F W Grannis
Abstract: http://links.ealert.nature.com/ctt?kn=73&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=72&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Social and geographical factors affecting access to
treatment of lung cancer
S M Crawford, V Sauerzapf, R Haynes, H Zhao, D Forman
and A P Jones
Abstract: http://links.ealert.nature.com/ctt?kn=106&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=107&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Impact of tumour size on axillary involvement and distant
dissemination in breast cancer
S Koscielny, R Arriagada, J Adolfsson, T Fornander and
J Bergh
Abstract: http://links.ealert.nature.com/ctt?kn=14&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=16&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
A randomised phase III trial comparing gemcitabine with
surgery-only in patients with resected pancreatic cancer: Japanese
Study Group of Adjuvant Therapy for Pancreatic Cancer
H Ueno, T Kosuge, Y Matsuyama, J Yamamoto, A Nakao, S Egawa,
R Doi, M Monden, T Hatori, M Tanaka, M Shimada and K Kanemitsu
Abstract: http://links.ealert.nature.com/ctt?kn=15&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=19&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Prospective study of predictors of vitamin D status and survival
in patients with colorectal cancer
K Ng, B M Wolpin, J A Meyerhardt, K Wu, A T Chan, B W Hollis,
E L Giovannucci, M J Stampfer, W C Willett and C S Fuchs
Abstract: http://links.ealert.nature.com/ctt?kn=18&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=22&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Preoperative downstaging chemoradiation with concurrent irinotecan
and capecitabine in MRI-defined locally advanced rectal cancer:
a phase I trial (NWCOG-2)
S W Gollins, S Myint, S Susnerwala, B Haylock, M Wise, C Topham,
L Samuel, R Swindell, J Morris, L Mason and E Levine
Abstract: http://links.ealert.nature.com/ctt?kn=21&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=24&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Prostate cancer as a first and second cancer: effect of family history
H Zhang, J L Bermejo, J Sundquist and K Hemminki
Abstract: http://links.ealert.nature.com/ctt?kn=23&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=77&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
----------------------
TRANSLATIONAL THERAPEUTICS
----------------------
Inhibition of human tumour prostate PC-3 cell growth by cannabinoids
R(+)-Methanandamide and JWH-015: Involvement of CB2
N Olea-Herrero, D Vara, S Malagarie-Cazenave and I Diaz-Laviada
Abstract: http://links.ealert.nature.com/ctt?kn=88&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=89&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Increased expression of class III [beta]-tubulin in
castration-resistant human prostate cancer
S Terry, G Ploussard, Y Allory, N Nicolaiew, F Boissiere-Michot,
P Maille, L Kheuang, E Coppolani, A Ali, F Bibeau, S Culine,
R Buttyan, A de la Taille and F Vacherot
Abstract: http://links.ealert.nature.com/ctt?kn=86&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=87&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Induction of thrombospondin-1 partially mediates the anti-angiogenic
activity of dexrazoxane
S L Maloney, D C Sullivan, S Suchting, J M J Herbert, E M Rabai,
Z Nagy, J Barker, S Sundar and R Bicknell
Abstract: http://links.ealert.nature.com/ctt?kn=83&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=84&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
----------------------
MOLECULAR DIAGNOSTICS
----------------------
Expression of activated signal transducer and activator of
transcription-3 predicts poor prognosis in cervical
squamous-cell carcinoma
S Takemoto, K Ushijima, K Kawano, T Yamaguchi, A Terada, N Fujiyoshi,
S Nishio, N Tsuda, M Ijichi, T Kakuma, M Kage, D Hori and T Kamura
Abstract: http://links.ealert.nature.com/ctt?kn=81&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=82&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Expression, mutation and copy number analysis of platelet-derived
growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas
O Martinho, A Longatto-Filho, M B K Lambros, A Martins, C Pinheiro,
A Silva, F Pardal, J Amorim, A Mackay, F Milanezi, N Tamber,
K Fenwick, A Ashworth, J S Reis-Filho, J M Lopes and R M Reis
Abstract: http://links.ealert.nature.com/ctt?kn=78&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=80&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
CD26 expression on T cell lines increases SDF-1-[alpha]-mediated
invasion
P A Havre, M Abe, Y Urasaki, K Ohnuma, C Morimoto and N H Dang
Abstract: http://links.ealert.nature.com/ctt?kn=108&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=109&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Intact and cleaved forms of the urokinase receptor enhance
discrimination of cancer from non-malignant conditions in patients
presenting with symptoms related to colorectal cancer
A F Lomholt, G Hoyer-Hansen, H J Nielsen and I J Christensen
Abstract: http://links.ealert.nature.com/ctt?kn=110&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=99&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Molecular markers of response and toxicity to FOLFOX chemotherapy
in metastatic colorectal cancer
W Chua, D Goldstein, C K Lee, H Dhillon, M Michael, P Mitchell,
S J Clarke and B Iacopetta
Abstract: http://links.ealert.nature.com/ctt?kn=101&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=103&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Securin promotes the identification of favourable outcome in invasive
breast cancer
K Talvinen, H Karra, S Hurme, M Nykanen, A Nieminen, J Anttinen,
T Kuopio and P Kronqvist
Abstract: http://links.ealert.nature.com/ctt?kn=105&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=91&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
----------------------
GENETICS AND GENOMICS
----------------------
Gross genomic damage measured by DNA image cytometry independently
predicts gastric cancer patient survival
J A M Belien, T E Buffart, A J Gill, M A M Broeckaert, P Quirke,
G A Meijer and H I Grabsch
Abstract: http://links.ealert.nature.com/ctt?kn=94&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=96&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Tumour necrosis factor gene polymorphism: a predictive factor for
the development of post-transplant lymphoproliferative disease
K A McAulay, T Haque and D H Crawford
Abstract: http://links.ealert.nature.com/ctt?kn=55&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Article: http://links.ealert.nature.com/ctt?kn=56&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
----------------------
LETTERS TO THE EDITOR
----------------------
Inflammatory breast carcinoma as a model of accelerated
self-metastatic expansion by intravascular growth
P B Vermeulen, S J Van Laere and L Y Dirix
http://links.ealert.nature.com/ctt?kn=53&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Reply: Inflammatory breast carcinoma as a model of accelerated
self-metastatic expansion by intra-vascular growth
H Enderling, L Hlatky and P Hahnfeldt
http://links.ealert.nature.com/ctt?kn=48&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
----------------------
CORRIGENDA
----------------------
Uracil-tegafur and tamoxifen versus cyclophosphamide, methotrexate,
fluorouracil, and tamoxifen in postoperative adjuvant therapy for
stage I, II, or IIIA lymph node-positive breast cancer: a
comparative study
Y Park, K Okamura, S Mitsuyama, T Saito, J Koh, S Kyono, K Higaki,
M Ogita, T Asaga, H Inaji, H Komichi, N Kohno, K Yamazaki, F Tanaka,
T Ito, H Nishikawa, A Osaki, H Koyama and T Suzuki
http://links.ealert.nature.com/ctt?kn=46&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
Clinical outcome data for symptomatic breast cancer: the Breast
Cancer Clinical Outcome Measures (BCCOM) project
T Bates, O Kearins, I Monypenny, C Lagord and G Lawrence
http://links.ealert.nature.com/ctt?kn=50&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
---------------------------------------------------------------------
Ensure your access to British Journal of Cancer
If you are unable to access the articles in this Table of Contents
e-alert, your library may not subscribe to this journal. Our online
recommendation form is a simple way to make your librarian aware
that this journal is valuable to your research.
Recommend now at
http://links.ealert.nature.com/ctt?kn=29&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0.
=====================================================================
You have been sent this Table of Contents Alert because you have opted in to receive it.
You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at:
http://links.ealert.nature.com/ctt?kn=28&m=34022848&r=MTc2MDAwMTgxNgS2&b=2&j=NTc3NDY2ODQS1&mt=1&rt=0
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne - San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.
© Copyright 2009 Nature Publishing Group
=====================================================================
